Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
195.83
-1.31 (-0.66%)
Dec 26, 2025, 4:00 PM EST - Market closed
Ligand Pharmaceuticals Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$239.33
Upside
+22.21%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $234 → $235 | Buy | Maintains | $234 → $235 | +20.00% | Dec 10, 2025 |
| Stifel | Stifel | Strong Buy Maintains $220 → $230 | Strong Buy | Maintains | $220 → $230 | +17.45% | Dec 10, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $270 | Strong Buy | Initiates | $270 | +37.87% | Dec 9, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $185 → $234 | Buy | Maintains | $185 → $234 | +19.49% | Nov 10, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $175 → $220 | Strong Buy | Maintains | $175 → $220 | +12.34% | Nov 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $206 → $231 | Strong Buy | Maintains | $206 → $231 | +17.96% | Nov 6, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $190 → $250 | Buy | Maintains | $190 → $250 | +27.66% | Nov 3, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $167 → $190 | Buy | Maintains | $167 → $190 | -2.98% | Sep 3, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $160 → $175 | Strong Buy | Maintains | $160 → $175 | -10.64% | Sep 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $157 → $206 | Strong Buy | Maintains | $157 → $206 | +5.19% | Aug 28, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $155 → $185 | Buy | Maintains | $155 → $185 | -5.53% | Aug 8, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $145 → $162 | Buy | Maintains | $145 → $162 | -17.28% | Jul 30, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $142 → $145 | Buy | Maintains | $142 → $145 | -25.96% | May 9, 2025 |
| Stifel | Stifel | Strong Buy Initiates $143 | Strong Buy | Initiates | $143 | -26.98% | Apr 10, 2025 |
| Benchmark | Benchmark | Strong Buy Reiterates $135 | Strong Buy | Reiterates | $135 | -31.06% | Dec 23, 2024 |
| Barclays | Barclays | Buy Maintains $150 → $160 | Buy | Maintains | $150 → $160 | -18.30% | Dec 16, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.